Home/Filings/4/0001562180-25-006194
4//SEC Filing

Simpson Curran 4

Accession 0001562180-25-006194

CIK 0001590877other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 4:30 PM ET

Size

5.5 KB

Accession

0001562180-25-006194

Insider Transaction Report

Form 4
Period: 2025-09-10
Simpson Curran
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-09-10$10.02/sh7,734$77,495244,597 total
Footnotes (2)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $10.00 to $10.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001346164

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:30 PM ET
Size
5.5 KB